Cargando…

Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer

BACKGROUND: Expression of integrin α3β1 is associated with tumor progression, metastasis, and poor prognosis in several cancers, including breast cancer. Moreover, preclinical studies have revealed important pro-tumorigenic and pro-metastatic functions for this integrin, including tumor growth, surv...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggarwal, Anshu, Al-Rohil, Rami N, Batra, Anupam, Feustel, Paul J, Jones, David M, DiPersio, C Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069347/
https://www.ncbi.nlm.nih.gov/pubmed/24950714
http://dx.doi.org/10.1186/1471-2407-14-459
_version_ 1782322535354859520
author Aggarwal, Anshu
Al-Rohil, Rami N
Batra, Anupam
Feustel, Paul J
Jones, David M
DiPersio, C Michael
author_facet Aggarwal, Anshu
Al-Rohil, Rami N
Batra, Anupam
Feustel, Paul J
Jones, David M
DiPersio, C Michael
author_sort Aggarwal, Anshu
collection PubMed
description BACKGROUND: Expression of integrin α3β1 is associated with tumor progression, metastasis, and poor prognosis in several cancers, including breast cancer. Moreover, preclinical studies have revealed important pro-tumorigenic and pro-metastatic functions for this integrin, including tumor growth, survival, invasion, and paracrine induction of angiogenesis. Our previously published work in a preclinical breast cancer model showed that integrin α3β1 promotes expression of cyclooxygenase-2 (COX2/PTGS2), a known driver of breast cancer progression. However, the clinical significance of this regulation was unknown. The objective of the current study was to assess the clinical relevance of the relationship between integrin α3β1 and COX2 by testing for their correlated expression among various forms of human breast cancer. METHODS: Immunohistochemistry was performed to assess co-expression of α3 and COX2 in specimens of human invasive ductal carcinoma (IDC), either on a commercial tissue microarray (n = 59 samples) or obtained from Albany Medical Center archives (n = 68 samples). Immunostaining intensity for the integrin α3 subunit or COX2 was scored, and Spearman’s rank correlation coefficient analysis was performed to assess their co-expression across and within different tumor subtypes or clinicopathologic criteria. RESULTS: Although expression of integrin α3 or COX2 varied among clinical IDC samples, a statistically significant, positive correlation was detected between α3 and COX2 in both tissue microarrays (r(s) = 0.49, p < 0.001, n = 59) and archived samples (r(s) = 0.59, p < 0.0001, n = 68). In both sample sets, this correlation was independent of hormone receptor status, histological grade, or disease stage. CONCLUSIONS: COX2 and α3 are correlated in IDC independently of hormone receptor status or other clinicopathologic features, supporting the hypothesis that integrin α3β1 is a determinant of COX2 expression in human breast cancer. These results support the clinical relevance of α3β1-dependent COX2 gene expression that we reported previously in breast cancer cells. The findings also suggest that COX2-positive breast carcinomas of various subtypes might be vulnerable to therapeutic strategies that target α3β1, and that α3 expression might serve as an independent prognostic biomarker.
format Online
Article
Text
id pubmed-4069347
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40693472014-06-26 Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer Aggarwal, Anshu Al-Rohil, Rami N Batra, Anupam Feustel, Paul J Jones, David M DiPersio, C Michael BMC Cancer Research Article BACKGROUND: Expression of integrin α3β1 is associated with tumor progression, metastasis, and poor prognosis in several cancers, including breast cancer. Moreover, preclinical studies have revealed important pro-tumorigenic and pro-metastatic functions for this integrin, including tumor growth, survival, invasion, and paracrine induction of angiogenesis. Our previously published work in a preclinical breast cancer model showed that integrin α3β1 promotes expression of cyclooxygenase-2 (COX2/PTGS2), a known driver of breast cancer progression. However, the clinical significance of this regulation was unknown. The objective of the current study was to assess the clinical relevance of the relationship between integrin α3β1 and COX2 by testing for their correlated expression among various forms of human breast cancer. METHODS: Immunohistochemistry was performed to assess co-expression of α3 and COX2 in specimens of human invasive ductal carcinoma (IDC), either on a commercial tissue microarray (n = 59 samples) or obtained from Albany Medical Center archives (n = 68 samples). Immunostaining intensity for the integrin α3 subunit or COX2 was scored, and Spearman’s rank correlation coefficient analysis was performed to assess their co-expression across and within different tumor subtypes or clinicopathologic criteria. RESULTS: Although expression of integrin α3 or COX2 varied among clinical IDC samples, a statistically significant, positive correlation was detected between α3 and COX2 in both tissue microarrays (r(s) = 0.49, p < 0.001, n = 59) and archived samples (r(s) = 0.59, p < 0.0001, n = 68). In both sample sets, this correlation was independent of hormone receptor status, histological grade, or disease stage. CONCLUSIONS: COX2 and α3 are correlated in IDC independently of hormone receptor status or other clinicopathologic features, supporting the hypothesis that integrin α3β1 is a determinant of COX2 expression in human breast cancer. These results support the clinical relevance of α3β1-dependent COX2 gene expression that we reported previously in breast cancer cells. The findings also suggest that COX2-positive breast carcinomas of various subtypes might be vulnerable to therapeutic strategies that target α3β1, and that α3 expression might serve as an independent prognostic biomarker. BioMed Central 2014-06-20 /pmc/articles/PMC4069347/ /pubmed/24950714 http://dx.doi.org/10.1186/1471-2407-14-459 Text en Copyright © 2014 Aggarwal et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Aggarwal, Anshu
Al-Rohil, Rami N
Batra, Anupam
Feustel, Paul J
Jones, David M
DiPersio, C Michael
Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer
title Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer
title_full Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer
title_fullStr Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer
title_full_unstemmed Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer
title_short Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer
title_sort expression of integrin α3β1 and cyclooxygenase-2 (cox2) are positively correlated in human breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069347/
https://www.ncbi.nlm.nih.gov/pubmed/24950714
http://dx.doi.org/10.1186/1471-2407-14-459
work_keys_str_mv AT aggarwalanshu expressionofintegrina3b1andcyclooxygenase2cox2arepositivelycorrelatedinhumanbreastcancer
AT alrohilramin expressionofintegrina3b1andcyclooxygenase2cox2arepositivelycorrelatedinhumanbreastcancer
AT batraanupam expressionofintegrina3b1andcyclooxygenase2cox2arepositivelycorrelatedinhumanbreastcancer
AT feustelpaulj expressionofintegrina3b1andcyclooxygenase2cox2arepositivelycorrelatedinhumanbreastcancer
AT jonesdavidm expressionofintegrina3b1andcyclooxygenase2cox2arepositivelycorrelatedinhumanbreastcancer
AT dipersiocmichael expressionofintegrina3b1andcyclooxygenase2cox2arepositivelycorrelatedinhumanbreastcancer